ALLURION TECHNOLOGIES, INC.

ALURW

Held by 1 specialist biotech fund

Share on X

Fund Holdings

RTW Investments

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

RTW InvestmentsNEWFeb 17, 2026

Shares: 5,891,430Value: $7.2M

**Signal Note: RTW Investments enters ALURION** RTW's $7.2M initiation in Allurion (gastric balloon for weight loss) signals confidence in the obesity treatment market expansion following GLP-1 competition. Key catalysts to monitor: FDA reimbursement decisions, commercial execution on direct-to-consumer model, and competitive positioning against pharmacological alternatives as pricing pressure mounts in the space.

More ALURW Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

NBIX1 fund FDMT1 fund GHRS1 fund IMCR1 fund IVEVF1 fund LRMR1 fund QURE1 fund ZLAB

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: